SEC filings

2021

• April 7, 2020 Annual report on Form 20-F submitted to the U.S. Securities and Exchange Commission

• April 7, 2021 6-K "Pharming Group announces the filing of its 2020 Annual Report on Form 20-F with the U.S. Securities and Exchange Commission"

• April 6, 2021 6-K ''Pharming Group announces the publication of its 2020 Annual Report and convenes its 2021 AGM''

• March 23, 2021 6-K "Pharming Group announces the intention to nominate three Non-Executive Directors to the Board of Directors"

• March 16, 2021 6-K "Pharming Group to present at 31st Annual Oppenheimer Healthcare"

• March 11, 2021 6-K "Pharming Group to Present at BioCapital Europe 2021" 

• March 4, 2021 6-K "Pharming Group reports financial results for full year 2020" 

• March 2, 2021 6-K "Pharming Group, in collaboration with Invitae Corporation, launches genetic testing program ‘navigateAPDS’"

2020

• December 22, 2020 6-K: "Pharming Group announces ADSs admitted to trade on Nasdaq under the symbol “PHAR”"

• December 22, 2020 6-K: "Pharming Announces Instructions for Exchanging Listed Ordinary Shares into Nasdaq Listed ADSs Costs for conversion of Ordinary Shares into ADS’s waived by JP Morgan Chase for initial four weeks after today"

• December 22, 2020 F-1 Registration Statement

To view all Company SEC filings please visit the SEC's website here: https://sec.report/T/PHAR